APTIMA INC — Department of Defense SBIR Phase II: DHA PHASE II SBIR MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2-0810
APTIMA INC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,983 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Aptima Inc received a Phase II SBIR award of nearly $1.3 million from the Defense Health Agency. The contract funds medical research and development work for the Department of Defense.
- Amount
- $1,299,983
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MA
- Period
- 2025-02-12 → 2027-06-11
Technology domains
Description
DHA PHASE II SBIR MEDICAL R&D CONTRACT FROM PROPOSAL NO. H2-0810